Biovic Consulting S.L. came to NPCS with a clear sense of direction — they wanted to invest in large-scale food manufacturing, and they wanted it to be something with genuine long-term relevance. Plant-based nutrition was the space they were circling. What they needed was a specific product, a credible market case, and a realistic picture of what it would actually take to build and operate the facility.

After screening the European food ingredient landscape, NPCS identified pea protein isolate as the strongest candidate. The reasoning was straightforward. Yellow peas are grown in abundance across Europe, keeping raw material supply chains short and manageable. Consumer demand for clean-label, plant-based protein is growing structurally — not as a passing trend, but as a genuine shift in how European consumers think about food. And the production gap is real: Europe currently imports significant volumes of pea protein isolate, which means a well-positioned domestic manufacturer has an immediate and defensible market entry.

The numbers reflect that opportunity. The European pea protein market was valued at around USD 556 million in 2023 and is growing at roughly 11.6% annually. By 2033, the market is projected to reach USD 850 million. Spain, where Biovic Consulting S.L. is headquartered, is an emerging food innovation hub with proximity to both agricultural supply and European distribution networks.

On the technical side, the process selected was wet fractionation — the established method for producing pea protein isolate at food-grade purity levels of 85–90% and above. NPCS documented the full eight-stage manufacturing process, from raw material sourcing and de-hulling through alkaline extraction, centrifugation, isoelectric precipitation, neutralisation, and spray drying. Each stage was mapped to specific equipment requirements, including decanter and disc stack centrifuges, pH dosing systems, industrial spray dryers, and CIP/SIP hygiene infrastructure. The output is a premium ingredient used across plant-based meat, sports nutrition, and dairy alternative applications — product segments with strong and growing buyer bases.

The financial model built for Biovic Consulting S.L. covers a capital investment range of USD 8–15 million depending on the capacity chosen, with initial production capacity of 2,000–5,000 metric tonnes per year. By year three at full utilisation, revenues are estimated at USD 12–22 million. Gross margins in the 35–45% range reflect the premium positioning of food-grade isolate. IRR runs between 18–26% across scenarios, payback is estimated at four to six years, and break-even sits at 55–65% of installed capacity — achievable relatively early in the production ramp.

Biovic Consulting S.L. reviewed the completed feasibility study and moved forward with implementation planning. NPCS continues to support the project through the next phase.